ACHALUMINUM CORP OF CHINA LTD
- BusinessWire
Accendra Health Announces Adoption of Tax Asset Preservation Plan To Protect Long Term Shareholder Value
Accendra Health, Inc. (NYSE:ACH) (the Company) announced today that its Board of Directors adopted a Section 382 Rights Agreement (the "Tax Asset Preservation Plan") designed to protect long-term shareholder ...
- BusinessWire
Accendra Health Reports Second Quarter 2026 Financial Results
Reduced Total Debt By $385 Million In Second Quarter CEO Ed Pesicka Announces Intention To Retire By The End of 2026 Accendra Health, Inc. (NYSE:ACH) (the Company) today reported financial results for the second ...
- BusinessWire
Accendra Health’s Ed Pesicka Announces Intent to Retire; Board of Directors Has Begun Successor Search
Accendra Health, Inc. (NYSE:ACH) (the Company) today announced that President and Chief Executive Officer Edward A. Pesicka has informed the Board of Directors of his plan to retire by the end of 2026, after more than ...
- BusinessWire
Accendra Health Announces Leadership Appointments in IT and Procurement
Accendra Health today announced key leadership appointments in Information Technology and Procurement, reinforcing our commitment to building a stronger operational foundation and positioning the company for long-term ...
- BusinessWire
Accendra Health Announces Second Quarter 2026 Earnings Release Date and Conference Call
Accendra Health, Inc. (NYSE:ACH) (the "Company") plans to release financial results for the second quarter of 2026 on Monday, August 10, 2026, before trading begins on the New York Stock Exchange. The Company ...
- Analyst Upgrades
Citigroup Maintains Buy on Accendra Health, Lowers Price Target to $4.5
Citigroup analyst Daniel Grosslight maintains Accendra Health with a Buy and lowers the price target from $5 to $4.5. ...
- BusinessWire
Accendra Health Announces Expiration and Final Results of Offers and Consent Solicitations
Accendra Health, Inc. (NYSE:ACH) (the "Company") today announced the expiration and final results of the previously announced offers to exchange (the "Exchange Offers") any and all of the Company’s ...
- BusinessWire
Accendra Health Announces Early Results of Offers and Consent Solicitations
Accendra Health, Inc. (NYSE:ACH) (the "Company") today announced the early results of the previously announced offers to exchange (the "Exchange Offers") any and all of the Company's outstanding 4.500% Senior Notes due ...
- BusinessWire
Accendra Health Announces Offers and Consent Solicitations
Accendra Health, Inc. (NYSE:ACH) (the "Company") today announced that it has commenced an offer to exchange (the "Exchange Offers") any and all of the Company's outstanding 4.500% Senior Notes due 2029 (the "2029 ...
- Analyst Upgrades
UBS Maintains Neutral on Accendra Health, Raises Price Target to $4.5
UBS analyst Kevin Caliendo maintains Accendra Health with a Neutral and raises the price target from $3 to $4.5. ...
- Analyst Upgrades
Citigroup Maintains Buy on Accendra Health, Raises Price Target to $5
Citigroup analyst Daniel Grosslight maintains Accendra Health with a Buy and raises the price target from $3.25 to $5. ...
- Analyst Upgrades
Baird Maintains Outperform on Accendra Health, Raises Price Target to $6
Baird analyst Eric Coldwell maintains Accendra Health with a Outperform and raises the price target from $5 to $6. ...
- BusinessWire
Accendra Health Reports First Quarter 2026 Financial Results and Announces Comprehensive Balance Sheet Optimization Transaction
Commitments in Place from Existing Creditors to Strengthen Balance Sheet, Extend Maturities, and Reduce Leverage Accendra Health, Inc. (NYSE:ACH) today reported financial results for the first quarter ended March 31, ...
- BusinessWire
Accendra Health Announces First Quarter 2026 Earnings Release Date and Conference Call
Accendra Health, Inc. (NYSE:ACH) (the "Company") plans to release financial results for the first quarter of 2026 on Monday, May 11, 2026, before trading begins on the New York Stock Exchange. The Company will host a ...
- Analyst Upgrades
Leerink Partners Maintains Market Perform on Accendra Health, Lowers Price Target to $2.75
Leerink Partners analyst Michael Cherny maintains Accendra Health with a Market Perform and lowers the price target from $3 to $2.75. ...
- BusinessWire
Accendra Health Reports Fourth Quarter 2025 Financial Results
Completed Sale of Products & Healthcare Services Business On December 31, 2025 Strong Cash Flow and Debt Reduction In Quarter Accendra Health, Inc. (NYSE:ACH) today reported financial results for the fourth ...
- BusinessWire
Accendra Health Announces Fourth Quarter 2025 Earnings Release Date and Conference Call
Accendra Health, Inc. (NYSE:ACH) (the "Company") plans to release financial results for the fourth quarter of 2025 on Thursday, February 19, 2026, after trading ends on the New York Stock Exchange. The Company will ...
- Analyst Upgrades
Citigroup Maintains Buy on Accendra Health, Lowers Price Target to $4
Citigroup analyst Daniel Grosslight maintains Accendra Health with a Buy and lowers the price target from $7 to $4. ...
- SEC
6-K Form - Report of foreign issuer [Rules 13a-16 and 15d-16] - ALUMINUM CORP OF CHINA LTD (0001161611) (Filer)
Report of foreign issuer [Rules 13a-16 and 15d-16] ...
- SEC
6-K Form - Report of foreign issuer [Rules 13a-16 and 15d-16] - ALUMINUM CORP OF CHINA LTD (0001161611) (Filer)
Report of foreign issuer [Rules 13a-16 and 15d-16] ...
- SEC
6-K Form - Report of foreign issuer [Rules 13a-16 and 15d-16] - ALUMINUM CORP OF CHINA LTD (0001161611) (Filer)
Report of foreign issuer [Rules 13a-16 and 15d-16] ...
- SEC
6-K Form - Report of foreign issuer [Rules 13a-16 and 15d-16] - ALUMINUM CORP OF CHINA LTD (0001161611) (Filer)
Report of foreign issuer [Rules 13a-16 and 15d-16] ...
- SEC
6-K Form - Report of foreign issuer [Rules 13a-16 and 15d-16] - ALUMINUM CORP OF CHINA LTD (0001161611) (Filer)
Report of foreign issuer [Rules 13a-16 and 15d-16] ...
- SEC
6-K Form - Report of foreign issuer [Rules 13a-16 and 15d-16] - ALUMINUM CORP OF CHINA LTD (0001161611) (Filer)
Report of foreign issuer [Rules 13a-16 and 15d-16] ...
- SEC
6-K Form - Report of foreign issuer [Rules 13a-16 and 15d-16] - ALUMINUM CORP OF CHINA LTD (0001161611) (Filer)
Report of foreign issuer [Rules 13a-16 and 15d-16] ...